ISTH1047
/ Isarna Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 19, 2019
Therapeutic targeting of TGF-β ligands in glioblastoma using novel antisense oligonucleotides reduces the growth of experimental gliomas.
(PubMed, Clin Cancer Res)
- "Targeting TGF-β expression with the novel LNA antisense oligonucleotides ISTH1047 or ISTH0047 results in strong anti-glioma activity in vitro and in vivo which may represent a promising approach to be examined in human glioma patients."
Journal • Brain Cancer • Glioblastoma • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1